Browse by Medical Category
For more information or to make an appointment:
Our leading-edge medical, endoscopic, and surgical interventions provide patients with timely diagnosis and individualized, ongoing care for the entire spectrum of pancreatic and biliary diseases.
Each patient's treatment is overseen by a personal care team of pancreatic and biliary specialists that are all part of the MGH Digestive Healthcare Center:
The team works with both the patient and the referring physician to coordinate a care plan designed to offer the best outcomes.
Mass General is a leader in detecting early malignancies. We offer advanced endoscopic imaging techniques of the pancreas and biliary tract, including:
Mass General was one of the first U.S. hospitals to offer endoscopic retrograde cholangiopancreatography (ERCP), a minimally invasive procedure that combines X-ray and video endoscope technologies to diagnose and treat conditions of the bile ducts. We helped pioneered cholangioscopy, a new technique in ERCP, and have introduced other novel diagnostic and therapeutic approaches, some of which are available only at Mass General.
Other treatments include:
Our diagnostic radiology team is composed of dedicated imaging specialists whose practice focuses specifically on GI scans (CT, MRI, PET). They are also nationally recognized for expertise in using the most sophisticated imaging tests to detect, diagnose and biopsy lesions in the pancreatic-biliary system.
We take a collaborative, multidisciplinary approach that provides access to surgical expertise. Mass General has pioneered landmark pancreatic-biliary surgical procedures including: Sphincter of Oddi resection, Pancreatic cyst resection, Pancreaticoduodenectomy (Whipple Procedure), Distal pancreatectomy, Middle pancreatectomy, Cyst-gastrostomy, Pancreatic debridement or necrosectomy, Choledochojejunostomy, Pancreatico-jejunostomy, Laparoscopic cholecystectomy.
Learn more about pancreatic-biliary surgical procedures in the Department of Surgery
The National Pancreas Foundation (NPF) has recognized Mass General as both an NPF Pancreatic Cancer Center and an NPF Pancreatitis (non-cancerous) Center. These important recognitions are given to premier healthcare facilities that focus on the multidisciplinary treatment of pancreatic cancer and acute pancreatitis, best possible outcomes and improved quality of life for patients. Learn more about the NPF recognitions.
We are one of the largest referral centers nationally for patients with pancreatic and biliary disorders. We have expertise in the treatment of acute pancreatitis using a variety of approaches. We also have extensive experience treating pancreatic cysts and pancreatic cancer through the Cancer Center, including neuroendocrine tumors of the pancreas. Our pancreatic cancer patients have some of the best survival rates in the U.S.
We offer treatments for patients with the full range of pancreatic and biliary diseases, including a specialized Cyst Imaging Surveillance and Treatment (CIST) Center for pancreatic cysts.Benign conditions of the pancreatic-biliary system
Premalignant conditions of the pancreatic-biliary system
Malignant conditions of the pancreatic-biliary system
After referral and initiation of therapy, we work closely with both the patient and the referring physician on long-term care plans, striving to offer the best possible outcomes.
We provide patients and referring physicians with an experienced access coordinator, a clinician who helps assess patient needs, coordinate appointments and begin the appropriate testing regimen.
Contact the Pancreas and Biliary Center's access coordinator
Calls will be returned within 24 hours.
We are recognized as one of the nation's foremost research centers in the study of pancreatic and biliary malignancies. Our research focuses on prolonging and improving patients' lives and includes:
Our physicians are active in clinical trials and research studies related to pancreatic-biliary conditions, allowing us to bring our patients promising new treatments as quickly as possible. Patients interested in participating in clinical trials can browse online for open trials, including an ongoing study on endoscopic therapy of malignant bile duct strictures.
Accepting New Patients
Biliary cirrhosis is a rare form of liver cirrhosis, caused by disease or defects of the bile ducts.
Cholangitis is an inflammation of the bile duct system that is usually related to a bacterial infection. The bile duct system is the drainage system that carries bile from the liver and gallbladder into the area of the small intestine called the duodenum. The infection may occur suddenly or may be chronic.
Cholecystitis is an inflammation of the gallbladder wall and nearby abdominal lining. Cholecystitis is usually caused by a gallstone in the cystic duct, the duct that connects the gallbladder to the hepatic duct.
Gallstones form when bile stored in the gallbladder hardens into stone-like material.
Pancreatic cancer is the fourth most common cause of cancer death in men and women in the US. Pancreatic cancer occurs when malignant cells grow out of control.
Pancreatitis is the inflammation of the pancreas. The inflammation may be sudden (acute) or ongoing (chronic).
Pseudocysts of the pancreas are abnormal collections of fluid, dead tissue, pancreatic enzymes, and blood that can lead to a painful mass in the pancreas.
Patients seeking care for pancreatic and biliary system disorders at Massachusetts General Hospital’s Digestive Healthcare Center receive the latest in diagnostic and therapeutic treatments from a collaborative team of experts, including gastroenterologists, interventional endoscopists, pathologists, medical oncologists, surgeons, radiation oncologists, and radiation therapists.
Pancreas and Biliary Center
To begin the appointment process, contact the Pancreas and Biliary Center access coordinator at 617-643-5677 or request an appointment online.
Back to Top